2008 annual financial data
XTL Biopharmaceuticals 2008 Operating margin
Direct answer
Operating margin was -161.46%.
Operating income was -9,591,000 USD and net income was -9,246,000 USD.
Operating cash flow was -10,578,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,940,000 USD
- Operating income
- -9,591,000 USD
- Net income
- -9,246,000 USD
- Operating cash flow
- -10,578,000 USD